Tranexamic Acid Powder (TXA-99)

Description

1. Product Overview

Tranexamic Acid Powder (TXA-99) is a high-purity pharmaceutical-grade active ingredient used primarily in formulations designed to control excessive bleeding and support hemostatic applications. With a target purity of 99%, it provides consistent performance and reliable formulation characteristics for pharmaceutical manufacturers and healthcare product developers. Its established functionality, scalability, and broad pharmaceutical relevance make it a strategically important raw material for global sourcing programs.

2. Key Specifications & Technical Characteristics

• Chemical Name: Tranexamic Acid
• CAS Number: 1197-18-8
• Chemical Formula: C₈H₁₅NO₂
• Purity: ≥99%
• Grade: Pharmaceutical / industrial bulk grade, subject to applicable specification
• Physical Form: Fine crystalline powder
• Color: White to off-white
• Solubility: Soluble in water
• Packaging Options: 25 kg bags/drums; customized bulk packaging available
• Shelf Life: Typically 24–36 months when stored under recommended conditions
• Storage: Keep tightly sealed in a cool, dry, well-ventilated environment and protected from moisture

3. Core Industrial Applications

• Pharmaceutical Manufacturing: Used as an active pharmaceutical ingredient (API) in formulations intended for antifibrinolytic and hemostatic applications.
• Healthcare Products: Suitable for incorporation into tablets, capsules, injectable formulations, and other pharmaceutical dosage forms subject to regulatory requirements.
• Contract Manufacturing: Supports large-scale API procurement for pharmaceutical producers and contract manufacturing organizations.
• Formulation Development: Its high purity and consistent physical characteristics facilitate standardized formulation and production processes.
• Operational Advantages: Reliable assay consistency can support batch-to-batch reproducibility, efficient processing, and reduced formulation variability compared with lower-purity raw materials.

4. Competitive Advantages

• Quality Consistency: ≥99% purity specification supports dependable pharmaceutical manufacturing and formulation control.
• Supply Reliability: Suitable for structured bulk procurement and recurring industrial supply programs.
• Logistics Capability: Bulk packaging and container-scale shipment options support international sourcing requirements.
• Price Competitiveness: High-volume procurement enables commercially attractive cost structures for pharmaceutical manufacturers.
• Sustainability: Efficient bulk packaging and consolidated transportation can help optimize material handling and logistics efficiency.
• Technical Documentation: Certificate of Analysis (CoA), specification sheets, Safety Data Sheet (SDS), and other quality documentation can be provided subject to supplier and regulatory requirements.

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20 MT
• Loading Capacity: Approximately 20 MT per standard 20-foot container, subject to packaging configuration, applicable weight restrictions, and shipping requirements